NDC:59338-775-01活性物质:FERUMOXYTOL剂量:510 mg/ 17 mL服用方式:静脉注射NDA:NDA022180 首次上市时间:07/13/2009分销商:AMAG Pharmaceuticals, Inc.生产商一:Baxter Pharmaceutical Solutions生产商二:Patheon Manufacturing Services LLC说明书:PDF
药品名: ABILIFY MAINTENA KIT (ARIPIPRAZOLE) ANDA: NDA #202971 NDC:59148-019-71 制造公司: OTSUKA PHARM CO LTD 活性物质: ARIPIPRAZOLE 剂量: 400MG/VIAL 使用方式: FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 营销状态: Prescription 批准日期: 10/08/2014批准类型: Approval ...
产品名称:OCTREOTIDE ACETATE上市时间:02/21/2023NDA/ANDA/BLA:204669持证商:HERITAGE PHARMSNDC:23155-687-41,23155-688-41,23155-689-41说明书:批准信:
产品名称:OCTREOTIDE ACETATE上市时间:02/21/2023NDA/ANDA/BLA:203765持证商:HERITAGE PHARMSNDC:23155-685-31,23155-686-31说明书:批准信:
产品名称:OCTREOTIDE ACETATE (PRESERVATIVE FREE)上市时间:02/21/2023NDA/ANDA/BLA:79198持证商:MYLAN INSTITUTIONALNDC:67457-239-01,67457-246-01,67457-245-01说明书:批准信:
产品名称:OCTREOTIDE ACETATE (PRESERVATIVE FREE)上市时间:02/21/2023NDA/ANDA/BLA:79198持证商:MYLAN INSTITUTIONALNDC:67457-239-01,67457-246-01,67457-245-01说明书:批准信:
产品名称:OCTREOTIDE ACETATE (PRESERVATIVE FREE)上市时间:02/21/2023NDA/ANDA/BLA:79198持证商:MYLAN INSTITUTIONALNDC:67457-239-01,67457-246-01,67457-245-01说明书:批准信:
产品名称:DROPERIDOL上市时间:02/21/2023NDA/ANDA/BLA:72123持证商:AM REGENTNDC:0517-9702-25说明书:批准信:
产品名称:VOLTAREN ARTHRITIS PAIN上市时间:02/21/2023NDA/ANDA/BLA:22122持证商:GLAXOSMITHKLINE CONSNDC:0067-8152-01,0067-8152-02,0067-8152-03,0067-8152-04,0067-8153-01,63187-582-00,0067-8152-08,63187-753-00说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022122lbl.pdf批准信:https://www.accessdata.fda.go...
产品名称:ADVIL PM上市时间:02/21/2023NDA/ANDA/BLA:21394持证商:GLAXOSMITHKLINENDC:0093-7516-31,0093-7517-31,0093-7518-31,73216-110-01,73216-111-01,69117-0044-1,0573-0164-04,0573-0164-05,0573-0164-08,0573-0164-09,0573-0164-12,0573-0164-14,0573-0164-20,0573-0164-21,0573-0164-30,0573-0164-32,0573-0164-33,0573-0164-...
产品名称:VESANOID上市时间:02/21/2023NDA/ANDA/BLA:20438持证商:CHEPLAPHARMNDC:59676-701-01,31722-807-02,59676-702-60,78714-001-30,31722-807-32,31722-807-60,31722-808-02,31722-808-32,31722-808-60说明书:批准信:
产品名称:VESANOID上市时间:02/21/2023NDA/ANDA/BLA:20438持证商:CHEPLAPHARMNDC:59676-701-01,31722-807-02,59676-702-60,78714-001-30,31722-807-32,31722-807-60,31722-808-02,31722-808-32,31722-808-60说明书:批准信: